顯示具有 IPO 標籤的文章。 顯示所有文章
顯示具有 IPO 標籤的文章。 顯示所有文章

2026年5月20日 星期三

The Dying Pharmacy: Boots and the Mirage of the IPO

 

The Dying Pharmacy: Boots and the Mirage of the IPO

Boots, founded in 1849, is more than a store; it is the skeletal structure of the British High Street. Yet, over the last two decades, it has been treated less like a heritage brand and more like a used car passed between private equity firms. From the 2006 merger with Alliance Unichem to the clutches of KKR, Walgreens, and now Sycamore Partners, Boots has been gutted, flipped, and starved of the long-term investment required to survive the digital age. While a fresh coat of paint and some new makeup lines have nudged profits back into the green, the prospect of an IPO—the dream exit strategy for its current private equity masters—feels less like a financial inevitability and more like a desperate fantasy.

Why is an IPO in the next few years a pipe dream? First, the macroeconomic climate is brutal. Boots is a seller of cold medicine and moisturizer—a "dull" stock in an era that demands AI-driven growth. It cannot rely on the speculative mania that currently inflates tech valuations. Second, the UK has become a fiscal trap. With soaring National Insurance, crushing business rates, and the highest minimum wage pressures in the G7, the regulatory burden on physical retail is a slow-motion strangulation.

Third, the London Stock Exchange (LSE) is fast becoming a global backwater. International capital is flowing toward the US and emerging markets, viewing the LSE with the polite disinterest one shows a dying museum exhibit. Finally, there is the simple, cynical reality of capital allocation. In a world obsessed with space travel and generative AI, convincing a hedge fund manager to sink hundreds of millions into retail units in Doncaster or Cheltenham is a hard sell. There is no "fancy" story here—no revolutionary platform, no scalable software, just shelves of vitamins and eye exams.

History shows us that institutions which stop innovating and start prioritizing financial engineering over customer value eventually disappear. Boots may have survived this long, but it is surviving as a relic in a landscape that has moved on.